Product Information
BFH772 is a monoclonal antibody that binds to the IL-17 receptor. It has been shown to be effective in treating autoimmune diseases such as psoriasis, rheumatoid arthritis, and Crohn's disease. BFH772 also inhibits the binding of IL-17 to the IL-17 receptor, preventing activation of them. This drug is being investigated for use in treating cancer and choroidal neovascularization.
Chemical properties
Technical inquiry about: 3D-QKB12881 BFH772
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.